首页> 外文会议>Chiang Mai International Conference on Biomaterials and Applications >Comparison of Vehicles for Vancomycin Drug Delivery in Extemporaneously Prepared Ophthalmic Solutions
【24h】

Comparison of Vehicles for Vancomycin Drug Delivery in Extemporaneously Prepared Ophthalmic Solutions

机译:在临时制备的眼科溶液中的万古霉素药物递送车辆的比较

获取原文

摘要

This work compares the ophthalmic delivery of vancomycin 50 mg/ml eye drops using 5 different vehicles, namely: 0.3% w/v chitosan, 0.3% and 0.4% w/v HPMC (Methocel E4M), Tears Naturale II and 0.9% w/v sodium chloride solution. In vitro and in vivo studies were carried out and the results evaluated in terms of viscosity, compatibility, stability, clarity, minimum inhibitory concentration (MIC) and pharmacokinetics. The viscosity of Tears Naturale II was comparable with that of HPMC (0.3% pH 7.1) but was higher than 0.3% w/v chitosan. The percent labeled amounts and MIC of vancomycin 50 mg/ml in all of the vehicles were stable for 30 days at 2-8°C, while the clarity in 0.3% w/v chitosan, 0.3% and 0.4% HPMC (pH 7.1), Tears Naturale II and 0.9% sodium chloride solution was stable for 30, 14, 1 and 3 days respectively at 2-8°C. In vivo pharmacokinetic determinations of the AUC of tear film reciprocal of minimum inhibitory titer showed that vancomycin 50 mg/ml in 0.3% w/v chitosan, 0.3% and 0.4% w/v HPMC pH 7.1 and Tears Naturale II were significantly different from 0.9% sodium chloride solution. At the present time, chitosan is undergoing clinical trials in Thailand with a view to its use in ophthalmology, while HPMC (0.3% w/v) in pH 7.1 has already been approved for use as a vehicle in ophthalmology for the delivery of vancomycin 50 mg/ml in extemporaneous eye drops.
机译:这项工作比较了使用5种不同载体的万古霉素50mg / ml滴眼液的眼科递送,即:0.3%w / v壳聚糖,0.3%和0.4%w / v HPMC(Methocel E4M),撕裂Naturale II和0.9%w / v氯化钠溶液。进行体外和体内研究,并在粘度,相容性,稳定性,清晰度,最小抑制浓度(MIC)和药代动力学方面评价的结果。撕裂的粘度Naturale II与HPMC(0.3%pH7.1)的粘度相当,但高于0.3%w / v壳聚糖。所有载体中万常霉素50mg / ml的标记量和MIC在2-8℃下稳定30天,而澄清率为0.3%w / v壳聚糖,0.3%和0.4%HPMC(pH7.1) ,泪液Naturale II和0.9%氯化钠溶液分别在2-8℃下分别稳定为30,14,1和3天。在体内药代动力学测定的最小抑制滴度的泪膜往复式的测定表明,温霉素50mg / ml为0.3%w / v壳聚糖,0.3%和0.4%w / v hpmc pH 7.1和撕裂Naturale II的0.9显着不同%氯化钠溶液。目前,壳聚糖正在泰国进行临床试验,以其在眼科的使用,而PH 7.1中的HPMC(0.3%w / v)已被批准用于递送黄霉素50的眼科省力滴眼液中的mg / ml。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号